Entity Common Stock, Shares Outstanding of Theriva Biologics, Inc. from 10 Aug 2011 to 10 Mar 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Theriva Biologics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 10 Aug 2011 to 10 Mar 2026.
  • Theriva Biologics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 10 Mar 2026 was 45,892,668, a 1549% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Theriva Biologics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 45,892,668 +43,110,219 +1549% 10 Mar 2026 10-K 12 Mar 2026 2025 FY
Q3 2025 33,739,643 +30,957,194 +1113% 07 Nov 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 9,597,952 -15,533,278 -62% 07 Aug 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 2,782,449 -14,365,600 -84% 04 Mar 2025 10-K 06 Mar 2025 2024 FY
Q3 2024 2,782,449 -14,260,316 -84% 08 Nov 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 25,131,230 +8,088,465 +47% 09 Aug 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 17,148,049 +2,023,988 +13% 21 Mar 2024 10-K 25 Mar 2024 2023 FY
Q3 2023 17,042,765 +1,198,704 +7.6% 08 Nov 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 17,042,765 +1,198,704 +7.6% 02 Aug 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 15,124,061 -143,313,779 -90% 28 Mar 2023 10-K 30 Mar 2023 2022 FY
Q3 2022 15,844,061 -116,198,477 -88% 09 Nov 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 15,844,061 -116,198,477 -88% 10 Aug 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 158,437,840 +28,783,265 +22% 16 Mar 2022 10-K 16 Mar 2022 2021 FY
Q3 2021 132,042,538 +112,049,148 +560% 03 Nov 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 132,042,538 +112,602,192 +579% 03 Aug 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 129,654,575 +111,391,032 +610% 03 Mar 2021 10-K 04 Mar 2021 2020 FY
Q3 2020 19,993,390 +3,186,960 +19% 06 Nov 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 19,440,346 +2,633,916 +16% 03 Aug 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 18,263,543 +2,779,132 +18% 01 May 2020 10-Q 05 May 2020 2020 Q1
Q3 2019 16,806,430 +3,322,454 +25% 31 Oct 2019 10-Q 04 Nov 2019 2019 Q3
Q2 2019 16,806,430 -116,163,313 -87% 06 Aug 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 15,484,411 -113,082,455 -88% 26 Feb 2019 10-K 27 Feb 2019 2018 FY
Q3 2018 13,483,976 -115,082,907 -90% 07 Nov 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 132,969,743 +4,722,673 +3.7% 06 Aug 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 128,566,866 +11,024,888 +9.4% 06 May 2018 10-Q 08 May 2018 2018 Q1
Q3 2017 128,566,883 +36,394,169 +39% 31 Oct 2017 10-Q 01 Nov 2017 2017 Q3
Q2 2017 128,247,070 +36,977,484 +41% 31 Jul 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 117,541,978 +26,715,226 +29% 28 Feb 2017 10-K 02 Mar 2017 2016 FY
Q3 2016 92,172,714 +1,362,628 +1.5% 28 Oct 2016 10-Q 01 Nov 2016 2016 Q3
Q2 2016 91,269,586 +2,754,500 +3.1% 01 Aug 2016 10-Q 03 Aug 2016 2016 Q2
Q1 2016 90,826,752 +18,100,765 +25% 08 Mar 2016 10-K 10 Mar 2016 2015 FY
Q3 2015 90,810,086 +18,296,942 +25% 02 Nov 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 88,515,086 +30,061,558 +51% 06 Aug 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 72,725,987 +14,449,431 +25% 10 Mar 2015 10-K 16 Mar 2015 2014 FY
Q3 2014 72,513,144 +27,858,730 +62% 10 Nov 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 58,453,528 +13,799,114 +31% 08 Aug 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 58,276,556 +13,622,142 +31% 27 Mar 2014 10-K 31 Mar 2014 2013 FY
Q3 2013 44,654,414 +956,666 +2.2% 12 Nov 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 44,654,414 +11,258,876 +34% 12 Aug 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 44,654,414 +11,952,430 +37% 27 Mar 2013 10-K 16 Apr 2013 2012 FY
Q3 2012 43,697,748 +15,488,622 +55% 12 Nov 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 33,395,538 +5,267,894 +19% 09 Aug 2012 10-Q/A 11 Sep 2012 2012 Q2
Q1 2012 32,701,984 26 Mar 2012 10-K/A 11 May 2012 2011 FY
Q3 2011 28,209,126 10 Nov 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 28,127,644 10 Aug 2011 10-Q 15 Aug 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.